BlackRock, Inc. 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 12:19 pm Sale |
2025-02-28 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
11,284,399 7.100% |
-11,633,925 (-50.76%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
22,918,324 14.300% |
0 (Unchanged) |
Filing |
| 2024-10-23 5:04 pm Sale |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
22,918,324 14.300% |
-3,060,575 (-11.78%) |
Filing |
| 2024-01-22 2:03 pm Purchase |
2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
25,978,899 16.600% |
207,707 (+0.81%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
25,771,192 16.800% |
0 (Unchanged) |
Filing |
| 2023-01-20 5:17 pm Sale |
2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
25,771,192 16.800% |
-1,123,895 (-4.18%) |
Filing |
| 2022-07-08 4:57 pm Purchase |
2022-06-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
26,895,087 17.500% |
12,526,197 (+87.18%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
14,368,890 8.800% |
1,324,240 (+10.15%) |
Filing |
| 2021-01-29 5:23 pm Sale |
2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BlackRock Inc. BLK |
13,044,650 8.100% |
-496,895 (-3.67%) |
Filing |